Group 1 - The company plans to grant a total of 500,000 restricted stocks to 304 individuals, which includes middle and senior management as well as key technical and business personnel [1] - The proposed allocation of restricted stocks represents 20% of the total number of restricted stocks and 1.25% of the company's total share capital at the time of the plan announcement [1] - The company ensures that no individual can receive more than 1% of the total share capital through all valid stock incentive plans [1] Group 2 - The company will disclose relevant information about the incentive recipients in a timely and accurate manner after obtaining clear opinions from the assessment committee and legal opinions from lawyers [2]

Core Viewpoint - Anhui Kairun Co., Ltd. has approved the second vesting period of its 2023 restricted stock incentive plan, allowing 47 eligible participants to receive a total of 995,543 shares of restricted stock, following the fulfillment of specific vesting conditions [1][12][24]. Summary by Sections Implementation of the Incentive Plan - The company plans to grant a total of 3,272,127 restricted shares, representing approximately 1.37% of the total share capital of 239,791,155 shares [2][12]. - The grant price for the restricted shares is set at 8.33 yuan per share [2]. Vesting Conditions - The vesting of the restricted shares is contingent upon meeting performance targets, with the first vesting period requiring a minimum revenue growth of 10% for 2023 and the second period requiring a minimum growth of 15% for 2024, based on the average revenue from 2021-2022 [7][21]. - The vesting schedule allows for 50% of the shares to vest after 12 months and the remaining 50% after 24 months from the grant date [5][21]. Adjustments and Cancellations - A total of 839,113 shares have been canceled due to participants leaving the company or failing to meet performance criteria [12][13]. - The grant price has been adjusted from 8.33 yuan to 7.91 yuan per share due to dividend distributions [14][16]. Approval and Compliance - The board and supervisory committee have confirmed that the vesting conditions have been met and have approved the vesting of shares for the eligible participants [24][25]. - Legal opinions affirm that the company has complied with all necessary regulations and procedures regarding the incentive plan [26]. Financial Impact - The vesting of restricted shares is not expected to have a significant impact on the company's financial status or operational results, and the share distribution remains compliant with listing requirements [26].

Meeting Overview - The fourth meeting of the supervisory board of Shenzhen Mingyang Circuit Technology Co., Ltd. was held on August 26, 2025, combining on-site and remote voting methods [1] - The meeting was chaired by Mr. Qin Xiaohu, with three supervisors present, and the resolutions formed were deemed legal and effective [1] Financial Reporting - The supervisory board approved the "2025 Half-Year Report" and its summary, confirming that the report's preparation and review processes complied with relevant laws and regulations, accurately reflecting the company's actual situation without any false records or omissions [1][2] - The voting result for this agenda was 3 votes in favor, 0 against, and 0 abstentions [2] Fund Management - The supervisory board approved the "2025 Half-Year Special Report on the Storage, Management, and Use of Raised Funds," affirming that the report accurately reflects the company's fund management practices and complies with regulatory requirements [2][3] - The voting result for this agenda was also 3 votes in favor, 0 against, and 0 abstentions [2] Stock Incentive Plan - The supervisory board reviewed and approved the "2025 Restricted Stock Incentive Plan (Draft)" and its summary, stating that it meets legal requirements and is beneficial for the company's sustainable development [3][4] - The voting result for this agenda was 2 votes in favor, 0 against, and 0 abstentions, with one related supervisor abstaining due to a conflict of interest [4][5] Implementation Management - The supervisory board approved the "2025 Restricted Stock Incentive Plan Implementation Assessment Management Measures," which align with legal regulations and ensure the smooth implementation of the incentive plan [5][6] - The voting result for this agenda was 2 votes in favor, 0 against, and 0 abstentions, with the same related supervisor abstaining [5] Incentive Object Verification - The supervisory board verified the list of incentive objects for the "2025 Restricted Stock Incentive Plan," confirming that all candidates meet the necessary qualifications and do not include any inappropriate individuals [6][7] - The voting result for this agenda was 2 votes in favor, 0 against, and 0 abstentions, with the related supervisor abstaining [6] Documentation - The meeting resolutions and related documents are available for review [7]

Core Viewpoint - The article discusses the legal opinion regarding the adjustment of the 2025 Restricted Stock Incentive Plan of Huibo Yuntong Technology Co., Ltd, emphasizing compliance with relevant laws and regulations [2][4]. Group 1: Legal Framework and Compliance - The law firm, Beijing Jindu Law Firm Shanghai Branch, has been appointed as the legal advisor for the company's 2025 Restricted Stock Incentive Plan [2]. - The legal opinion is based on various laws including the Company Law, Securities Law, and relevant regulations from the China Securities Regulatory Commission [2][4]. - The firm confirms that all documents provided by the company are true, accurate, complete, and without any significant omissions [3][4]. Group 2: Approval and Authorization - On March 3, 2025, the company held its first extraordinary general meeting of shareholders, approving the draft of the 2025 Restricted Stock Incentive Plan and authorizing the board of directors to manage and adjust the plan [6]. - The board of directors and the supervisory board have reviewed and approved the adjustment of the repurchase price for the restricted stock [7]. Group 3: Adjustment Details - The repurchase price for the restricted stock was adjusted to 12.57 yuan per share, calculated based on the previous price and the dividend amount [7][8]. - The adjustment is in accordance with the provisions of the incentive plan and the decisions made in the board meetings [8]. Group 4: Conclusion - The law firm concludes that the company has obtained the necessary approvals for the adjustment and that the adjustment complies with the relevant regulations [9].

Summary of the 2024 Restricted Stock Incentive Plan of Tianshan Electronics Core Viewpoint The announcement details the implementation of the 2024 Restricted Stock Incentive Plan, highlighting the conditions for the first vesting period and the performance targets required for the vesting of restricted stocks. Group 1: Overview of the Incentive Plan - The 2024 Restricted Stock Incentive Plan was approved at the company's board meetings, allowing for the allocation of restricted stocks to key personnel [1][10]. - A total of 67.1104 thousand shares will be vested to 27 individuals, with an adjusted grant price of 6.54 yuan per share [2][15]. - The plan includes a total of 209.72 thousand shares, with 40% of the shares vesting in the first period [3][15]. Group 2: Vesting Conditions - The first vesting period is set from February 7, 2025, to February 6, 2026, with specific performance targets based on revenue growth [10][14]. - The performance targets for the first vesting period require an 8% revenue growth compared to 2023, with a trigger value of 6.5% [6][14]. - The company must not have any disqualifying events, such as negative audit opinions or failure to distribute profits legally, for the vesting conditions to be met [11][12]. Group 3: Performance Assessment - The performance assessment consists of both company-level and individual-level evaluations, with individual performance rated on a scale from A to D [7][8]. - If the company meets its performance targets, the actual number of shares vested will be calculated based on the company-level and individual-level performance ratios [8][15]. - The company has established a clear framework for the assessment, ensuring that unvested shares due to performance issues cannot be carried over to the next year [15][20]. Group 4: Financial Impact - The vesting of 67.1104 thousand shares will increase the total share capital from 197,572,840 to 198,243,944 shares, which may dilute earnings per share and return on equity [19][20]. - The company will account for the costs associated with the restricted stock in accordance with relevant accounting standards, ensuring transparency in financial reporting [18][19].

山东威高血液净化制品股份有限公司 第二届监事会第十次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 山东威高血液净化制品股份有限公司（以下简称"威高血净"或"公司"）第二届监 事会第十次会议于 2025 年 8 月 26 日以现场和通讯相结合的方式在公司会议室召开。 本次会议由监事会主席宋大鹏召集并主持，会议应出席监事 3 人，实际出席监事 3 人。本次会议的召集、召开和表决程序符合《中华人民共和国公司法》等法律、法 规、部门规章、规范性文件和《公司章程》的有关规定。 二、监事会会议审议情况 （一）审议通过了《关于公司 2025 年半年度报告全文及摘要的议案》 证券代码：603014 证券简称：威高血净 公告编号：2025-019 公司监事会认为：1、公司《山东威高血液净化制品股份有限公司 2025 年半年 度报告》编制和审议程序符合法律、法规、 《公司章程》和公司内部管理制度的规定； 的信息能从各个方面真实地反映出公司 2025 年上半年的经营管理和财务状况；3、 未发现参与半年度报告编制 ...

Core Viewpoint - The announcement details the achievement of the second unlock condition for the 2023 restricted stock incentive plan of Tongcheng New Materials Group Co., Ltd, allowing 154 eligible participants to unlock a total of 1,520,958 shares, representing approximately 0.25% of the company's total share capital [1][15][17]. Summary by Sections Incentive Plan Approval and Implementation - The 2023 restricted stock incentive plan has undergone necessary decision-making procedures, with independent directors expressing clear agreement on the related proposals [1][2]. - The company held a meeting on August 26, 2025, where the board approved the achievement of the second unlock condition for the incentive plan [1]. Historical Grant and Unlocking of Restricted Stocks - The first grant date was September 13, 2023, with a total of 4,804,000 shares granted at a price of 14.88 yuan per share [3][4]. - The second unlock period for the first grant will end on September 12, 2025, with specific conditions for unlocking [9][11]. Conditions for Unlocking - The unlocking of shares is contingent upon meeting specific performance targets, including a revenue growth rate of no less than 20% or a profit growth rate of no less than 30% for the fiscal year 2024 [11][12]. - The company achieved a revenue of 3,270.28 million yuan in 2024, reflecting a growth of 30.81% compared to 2022 [12]. Eligible Participants and Share Details - A total of 154 participants are eligible to unlock 1,520,958 shares, with specific allocations to key executives [15][18]. - The unlocking process will be conducted in accordance with the relevant regulations and will require necessary approvals [17][18].

首次授予限制性股票的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 限制性股票首次授予日：2025 年 8 月 25 日； 《上海联影医疗科技股份有限公司 2025 年限制性股票激励计划》 证券代码：688271 证券简称：联影医疗 公告编号：2025-035 上海联影医疗科技股份有限公司 关于向公司 2025 年限制性股票激励计划激励对象 （以下简称 "《激励计划》"或"本激励计划"）规定的限制性股票授予条件已经成就，根据 上海联影医疗科技股份有限公司（以下简称"公司"或"联影医疗"）2024 年年 度股东会的授权，公司于 2025 年 8 月 25 日召开第二届董事会第二十二次会议， 审议通过了《关于向公司 2025 年限制性股票激励计划激励对象首次授予限制性 股票的议案》，同意以 2025 年 8 月 25 日为首次授予日，并以 94.92 元/股的授予 价格向 1,368 名激励对象首次授予 447.13 万股限制性股票。现将有关事项说明 如下： 一、限制性股票授予情况 （一）本次限制性股 ...

证券代码：688277 证券简称：天智航 公告编号：2025-031 北京天智航医疗科技股份有限公司 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 北京天智航医疗科技股份有限公司（以下简称"公司"）第五届监事会第十 次会议通知于 2025 年 8 月 19 日以电子邮件方式送达公司全体监事，于 2025 年 次会议由监事会主席张维军先生主持。本次监事会会议的召开符合《公司法》 《公 司章程》等有关规定，会议决议合法有效。 二、监事会会议审议情况 全体监事以投票方式通过如下决议： 公司 2025 年半年度报告的编制和审议程序符合相关法律法规及《公司章程》 等相关规定；公司 2025 年半年度报告的内容和格式符合相关规定，公允地反映 了公司 2025 年半年度的财务状况和经营成果；2025 年半年度报告编制过程中， 未发现公司参与报告编制和审议的人员有违反保密规定的行为；监事会全体成员 保证公司 2025 年半年度报告披露的信息真实、准确、完整，不存在任何虚假记 载、误导性陈述或重大遗漏，并对其内容的 ...

2025年8月27日，罗博特科智能科技股份有限公司召开第三届董事会第三十一次会议、第三届监事会第 二十七次会议，审议通过了《关于调整2021年限制性股票激励计划的回购价格的议案》。 调整对公司影响 罗博特科此次调整2021年限制性股票激励计划回购价格，对公司财务状况和经营成果无重大影响，也不 会影响管理团队勤勉尽职。公司管理团队将继续为股东创造价值。监事会及律师均认为此次调整符合规 定及股东利益。 声明：市场有风险，投资需谨慎。 本文为AI大模型基于第三方数据库自动发布，任何在本文出现的信 息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成 个人投资建议。受限于第三方数据库质量等问题，我们无法对数据的真实性及完整性进行分辨或核验， 因此本文内容可能出现不准确、不完整、误导性的内容或信息，具体以公司公告为准。如有疑问，请联 系biz@staff.sina.com.cn。 点击查看公告原文>> 责任编辑：小浪快报 由于公司2021年限制性股票激励计划首次授予部分第一类限制性股票第三个解除限售期对应公司层面 2024年度业绩考核指标未达触发值，且1名获授第一类、第二类限制性股 ...